Table 2 Surgical and medical treatments used for G-NENs
From: Surgical treatment and prognosis of gastric neuroendocrine neoplasms: a single-center experience
Variables | Mean ± SD (Numbers/Percentage) |
|---|---|
Surgical approaches | |
Endoscopic resection | 25/135 (18.5 %) |
Open/Laparoscopic surgery | 110/135 (81.5 %) |
Types of gastrectomy* | |
Proximal gastrectomy | 38/110 (34.5 %) |
Distal gastrectomy | 39/110 (35.5 %) |
Total gastrectomy | 31/110 (28.2 %) |
Wedge resection | 2/110 (1.8) |
Multivisceral resection# | |
Gastrectomy + splenectomy | 2/110 (1.8 %) |
Gastrectomy + partial hepatectomy | 1/110 (0.9 %) |
Surgical margins | |
R0 | 114/135 (84.4 %) |
R1/R2 | 21/135 (15.6 %) |
Surgical complications | |
Abdominal infection | 2/135 (1.5 %) |
Intestinal obstruction | 3/135 (2.2 %) |
Alimentary tract bleeding | 5/135 (3.7 %) |
Pulmonary infection | 4/135 (3.0 %) |
Perioperative death | 0/135 (0.0 %) |
Postoperative medical treatments | |
Cytotoxic chemotherapy | 20 (14.8 %) |
Somatostatin analogs | 10 (7.4 %) |